Collectively, these outcomes suggested that SLC7A2 is differentially expressed in HNSCC with and without LNM, and HNSCC patients with low SLC7A2 expression have reduced survival, suggesting that SLC7A2 could be a possible prognostic factor. Here, SLC7A2 is linked to head and neck squamous cell carcinoma.